Why be a guinea pig?

Now that Tacrine has been approved for use in France as well as the US, should you encourage people with dementia and their carers to take part in trials of other drugs? John Kellett believes there are good reasons to do so.
Author/s: John Kellett

For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe.